GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
TRANSITION THERAPEUT (TTHI) [hlAlert]

Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company, developing therapeutics for disease indications with large markets. The Company?s lead products are ELND005 (AZD-103) for the treatment of Alzheimer?s disease, TT-223 for the treatment of diabetes, and TT-301 and TT-302,
which can have a therapeutic effect on CNS diseases, including Alzheimer?s disease, traumatic brain injury (TBI), multiple sclerosis (MS) and others. Transition also has a pipeline of preclinical drug candidates acquired externally or developed internally using its drug discovery engine. The Corporation has one wholly owned material subsidiary, Waratah Pharmaceuticals Inc. (Waratah). On August 18, 2008, it acquired certain assets and the rights to three drug discovery projects from Forbes Medi-Tech (Research) Inc., a wholly owned subsidiary of Forbes Medi-Tech Inc. (Forbes).
.
( Total: 4 Current Stock Recommendations )
TRANSITION THERAPEUT   (4)
Hold 25% Buy 75%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/19/2007  
Buy
  
3/6/2008  
Buy
  
4/18/2008  
Buy
  
12/15/2009  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy